가이드와이어 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 지역별, 부문별 예측(2024-2030년)

Guidewires Market Size, Share & Trends Analysis Report By Product (Coronary Guidewires, Peripheral Guidewires), By Region (North America, Europe), By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,152,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,522,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,262,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

가이드와이어 시장의 성장과 동향:

Grand View Research, Inc.의 최신 보고서에 따르면 세계 가이드와이어 시장 규모는 2023년부터 2030년까지 연평균 5.5% 성장하여 2030년에는 37억 7,000만 달러에 달할 것으로 예상됩니다.

이 시장은 최소침습수술의 증가, 만성질환의 유병률 증가, 노인 인구의 증가 등 다양한 요인으로 인해 예측 기간 동안 성장할 것으로 예상됩니다. 예를 들어, 2022년 11월 '고령화 행정' 보고서에 따르면, 미국에서는 2060년까지 65세 이상 인구가 9,500만 명에 달할 것으로 예측됩니다.

관상동맥질환 및 말초동맥질환과 같은 심혈관질환은 전 세계 보건에 중대한 도전이 되고 있습니다. 가이드와이어는 이러한 질환의 진단 및 치료에 필수적인 도구로, 의사가 복잡한 혈관망을 통과하여 정확하게 치료할 수 있도록 도와줍니다. 심혈관 질환의 이환율과 유병률이 증가함에 따라 가이드와이어에 대한 수요가 증가하여 시장 확대에 기여하고 있습니다. 예를 들어, 2022년 1월 미국심장협회(AHA)는 2030년까지 전 세계적으로 2,360만 명 이상의 심혈관 질환 환자가 발생할 것으로 예측했습니다.

또한 제품 개척, 적응, 마케팅 이니셔티브는 향후 제품 수요 증가를 촉진할 것입니다. 주요 업체들은 또한 개선을 위해 새로운 전술을 채택하고 있습니다. 예를 들어, 2022년 6월, Cardio Flow, Inc.는 뛰어난 지원을 제공하기 위해 만들어진 FreedomFlow Peripheral Guidewire에 대한 FDA 승인을 받았습니다. 이 장치는 무릎 위쪽과 아래쪽 모두에서 죽상동맥경화증 치료에 사용되는 진단 및 치료 기기에 대한 지원을 제공합니다. 이처럼 다양한 조직에서 기술 발전의 채택이 증가함에 따라 가이드와이어 산업은 2023년부터 2030년까지 급성장할 것으로 예측됩니다.

가이드와이어 시장 보고서 하이라이트

• 제품별로는 관상동맥 가이드와이어가 2023년 43.2%의 가장 큰 시장 점유율을 차지했는데, 이는 최소침습적 관상동맥 수술에 대한 수요가 높기 때문입니다. 동맥 경화증 환자의 입원 건수 증가와 심혈관 질환의 유병률 증가도 이 부문의 성장에 기여하고 있습니다.
• 북미는 심장 질환의 증가와 시장 내 주요 기업의 존재 등 다양한 요인으로 인해 2023년 35.2%의 가장 큰 매출 점유율을 차지했습니다.
• 아시아태평양의 가이드와이어 산업은 예측 기간 동안 가장 빠른 CAGR 6.45%를 기록할 것으로 예상됩니다. 성장 요인으로는 노인 인구 증가, 수술 건수 증가, 의료비 지출 증가 등을 들 수 있습니다.
• 시장 경쟁이 치열하여 MEDTRONIC, BD, B. Braun Melsungen AG, Terumo Medical Corporation, Cook, Teleflex Incorporated, Stryker, Abbott, and Boston Scientific Corporation 등이 진입했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 가이드와이어 시장 변수, 동향, 범위

• 시장 계통 전망
  • 상부 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 가이드와이어 시장 분석 툴
  • 업계 분석 - Porter's Five Forces 분석
  • PESTEL 분석

제4장 가이드와이어 시장 : 제품별 추정·동향 분석

• 부문 대시보드
• 가이드와이어 시장 : 제품별 변동 분석
• 가이드와이어 시장 : 제품별 전망
• 2018년부터 2030년까지 시장 규모와 예측 및 동향 분석
• 관상동맥 가이드와이어
• 말초 가이드와이어
• 비뇨기과 가이드와이어
• 신경혈관 가이드와이어

제5장 가이드와이어 시장 : 지역별 추정·동향 분석

• 지역 대시보드
• 가이드와이어 시장 : 지역별 변동 분석
• 가이드와이어 시장 : 진단별 지역 추정·동향 분석
• 2018년부터 2030년까지 시장 규모와 예측 및 동향 분석
• 북미
  • 북미 가이드와이어 시장 추정과 예측, 2018-2030년
  • 미국
  • 캐나다
  • 멕시코
  • 유럽
  • 유럽의 가이드와이어 시장 추정과 예측, 2018-2030년
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 아시아태평양 가이드와이어 시장 추정과 예측, 2018-2030년
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 라틴아메리카 가이드와이어 시장 추정과 예측, 2018-2030
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 중동 및 아프리카의 가이드와이어 시장 추정과 예측, 2018-2030년
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제6장 경쟁 상황

• 시장 진출 기업 분류
• 주요 기업 개요
  • Boston Scientific Corporation
  • Medtronic
  • Cook
  • B. Braun
  • Terumo Medical Corporation
  • Abbott
  • Stryker
  • Teleflex Incorporated
  • BD

ksm

영문 목차

영문목차

Guidewires Market Growth & Trends:

The global guidewires market size is expected to reach USD 3.77 billion by 2030, growing at a CAGR of 5.5% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to grow during the forecast period due to various factors such as the increasing number of minimally invasive surgeries, increasing prevalence of chronic diseases, and the rising geriatric population. For instance, in November 2022, the 'Administration on Aging' report projected that the number of people aged 65 and older will rise to 95 million by 2060 in the U.S.

Cardiovascular diseases such as coronary artery disease and peripheral arterial disease, pose significant challenges to global health. Guidewires are indispensable tools used in the diagnosis and treatment of these conditions, allowing physicians to navigate through complex networks of blood vessels and precisely deliver therapies. With the increasing incidence and prevalence of cardiovascular diseases, there is a growing need for guidewires, contributing to market expansion. For instance, in January 2022, The American Heart Association (AHA) projected that there will be more than 23.6 million cases of cardiovascular disease worldwide in 2030.

Additionally, product developments, adaptations, and marketing initiatives stimulate future increases in product demand. The major players have also adopted fresh tactics for their improvement. For instance, in June 2022, Cardio Flow, Inc., received FDA clearance for FreedomFlow Peripheral Guidewire, which was created to offer exceptional support. This device offers support for diagnostic and therapeutic devices used in treating Atherosclerosis, both above and below the knee. Thus, the growing adoption of technological advancement by various organizations is anticipated to upsurge the guidewire industry from 2023 to 2030.

Guidewires Market Report Highlights:

• By product, coronary guidewires accounted for the largest market share of 43.2% in 2023, owing to the high demand for minimally invasive coronary surgery. An increasing number of hospitalizations of atherosclerosis patients and the rising prevalence of cardiovascular disease also contribute to the segment growth
• The North American region held the largest revenue share of 35.2% in 2023 owing to various factors, such as the growing number of heart diseases and the presence of major players in the market
• Asia Pacific guidewires industry is expected to witness the fastest CAGR of 6.45% over the forecast period. Factors that can be attributed to growth include the rising geriatric population, increasing number of surgeries, and rising expenditure on healthcare
• The market is highly competitive with the presence of players including MEDTRONIC, BD, B. Braun Melsungen AG, Terumo Medical Corporation, Cook, Teleflex Incorporated, Stryker, Abbott, and Boston Scientific Corporation

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1 Segment Definitions
  • 1.1.2. Product
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecasts timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Diagnosis outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Guidewires Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Guidewires Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Guidewires Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Guidewires Market: Product Movement Analysis
• 4.3. Guidewires Market by Product Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Coronary Guidewires
  • 4.5.1. Coronary Guidewires Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Peripheral Guidewires
  • 4.6.1. Peripheral Guidewires Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Urology Guidewires
  • 4.7.1. Urology Guidewires Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Neurovascular Guidewires
  • 4.8.1. Neurovascular Guidewires Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Guidewires Market: Regional Estimates & Trend Analysis

• 5.1. Regional Dashboard
• 5.2. Regional Guidewires Market movement analysis
• 5.3. Guidewires Market: Regional Estimates & Trend Analysis by Diagnosis
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. North America
  • 5.5.1. North America Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.2. U.S.
    • 5.5.2.1. Key Country Dynamics
    • 5.5.2.2. Competitive Scenario
    • 5.5.2.3. Regulatory Framework
    • 5.5.2.4. Reimbursement scenario
    • 5.5.2.5. U.S. Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.3. Canada
    • 5.5.3.1. Key Country Dynamics
    • 5.5.3.2. Competitive Scenario
    • 5.5.3.3. Regulatory Framework
    • 5.5.3.4. Reimbursement scenario
    • 5.5.3.5. Canada Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.4. Mexico
    • 5.5.4.1. Key Country Dynamics
    • 5.5.4.2. Competitive Scenario
    • 5.5.4.3. Regulatory Framework
    • 5.5.4.4. Reimbursement scenario
    • 5.5.4.5. Mexico Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.5. Europe
  • 5.5.6. Europe Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.7. UK
    • 5.5.7.1. Key Country Dynamics
    • 5.5.7.2. Competitive Scenario
    • 5.5.7.3. Regulatory Framework
    • 5.5.7.4. Reimbursement scenario
    • 5.5.7.5. UK Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.8. Germany
    • 5.5.8.1. Key Country Dynamics
    • 5.5.8.2. Competitive Scenario
    • 5.5.8.3. Regulatory Framework
    • 5.5.8.4. Reimbursement scenario
    • 5.5.8.5. Germany Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.9. France
    • 5.5.9.1. Key Country Dynamics
    • 5.5.9.2. Competitive Scenario
    • 5.5.9.3. Regulatory Framework
    • 5.5.9.4. Reimbursement scenario
    • 5.5.9.5. France Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.10. Italy
    • 5.5.10.1. Key Country Dynamics
    • 5.5.10.2. Competitive Scenario
    • 5.5.10.3. Regulatory Framework
    • 5.5.10.4. Reimbursement scenario
    • 5.5.10.5. Italy Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.11. Spain
    • 5.5.11.1. Key Country Dynamics
    • 5.5.11.2. Competitive Scenario
    • 5.5.11.3. Regulatory Framework
    • 5.5.11.4. Reimbursement scenario
    • 5.5.11.5. Spain Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.12. Denmark
    • 5.5.12.1. Key Country Dynamics
    • 5.5.12.2. Competitive Scenario
    • 5.5.12.3. Regulatory Framework
    • 5.5.12.4. Reimbursement scenario
    • 5.5.12.5. Denmark Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.13. Sweden
    • 5.5.13.1. Key Country Dynamics
    • 5.5.13.2. Competitive Scenario
    • 5.5.13.3. Regulatory Framework
    • 5.5.13.4. Reimbursement scenario
    • 5.5.13.5. Sweden Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.14. Norway
    • 5.5.14.1. Key Country Dynamics
    • 5.5.14.2. Competitive Scenario
    • 5.5.14.3. Regulatory Framework
    • 5.5.14.4. Reimbursement scenario
    • 5.5.14.5. Norway Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Asia Pacific
  • 5.6.1. Asia Pacific Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.2. Japan
    • 5.6.2.1. Key Country Dynamics
    • 5.6.2.2. Competitive Scenario
    • 5.6.2.3. Regulatory Framework
    • 5.6.2.4. Reimbursement scenario
    • 5.6.2.5. Japan Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.3. China
    • 5.6.3.1. Key Country Dynamics
    • 5.6.3.2. Competitive Scenario
    • 5.6.3.3. Regulatory Framework
    • 5.6.3.4. Reimbursement scenario
    • 5.6.3.5. China Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.4. India
    • 5.6.4.1. Key Country Dynamics
    • 5.6.4.2. Competitive Scenario
    • 5.6.4.3. Regulatory Framework
    • 5.6.4.4. Reimbursement scenario
    • 5.6.4.5. India Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.5. South Korea
    • 5.6.5.1. Key Country Dynamics
    • 5.6.5.2. Competitive Scenario
    • 5.6.5.3. Regulatory Framework
    • 5.6.5.4. Reimbursement scenario
    • 5.6.5.5. South Korea Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.6. Australia
    • 5.6.6.1. Key Country Dynamics
    • 5.6.6.2. Competitive Scenario
    • 5.6.6.3. Regulatory Framework
    • 5.6.6.4. Reimbursement scenario
    • 5.6.6.5. Australia Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.7. Thailand
    • 5.6.7.1. Key Country Dynamics
    • 5.6.7.2. Competitive Scenario
    • 5.6.7.3. Regulatory Framework
    • 5.6.7.4. Reimbursement scenario
    • 5.6.7.5. Thailand Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Latin America
  • 5.7.1. Latin America Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7.2. Brazil
    • 5.7.2.1. Key Country Dynamics
    • 5.7.2.2. Competitive Scenario
    • 5.7.2.3. Regulatory Framework
    • 5.7.2.4. Reimbursement scenario
    • 5.7.2.5. Brazil Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7.3. Argentina
    • 5.7.3.1. Key Country Dynamics
    • 5.7.3.2. Competitive Scenario
    • 5.7.3.3. Regulatory Framework
    • 5.7.3.4. Reimbursement scenario
    • 5.7.3.5. Argentina Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Middle East & Africa
  • 5.8.1. Middle East & Africa Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8.2. South Africa
    • 5.8.2.1. Key Country Dynamics
    • 5.8.2.2. Competitive Scenario
    • 5.8.2.3. Regulatory Framework
    • 5.8.2.4. Reimbursement scenario
    • 5.8.2.5. South Africa Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8.3. Saudi Arabia
    • 5.8.3.1. Key Country Dynamics
    • 5.8.3.2. Competitive Scenario
    • 5.8.3.3. Regulatory Framework
    • 5.8.3.4. Reimbursement scenario
    • 5.8.3.5. Saudi Arabia Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8.4. UAE
    • 5.8.4.1. Key Country Dynamics
    • 5.8.4.2. Competitive Scenario
    • 5.8.4.3. Regulatory Framework
    • 5.8.4.4. Reimbursement scenario
    • 5.8.4.5. UAE Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8.5. Kuwait
    • 5.8.5.1. Key Country Dynamics
    • 5.8.5.2. Competitive Scenario
    • 5.8.5.3. Regulatory Framework
    • 5.8.5.4. Reimbursement scenario
    • 5.8.5.5. Kuwait Guidewires Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Market Participant Categorization
• 6.2. Key Company Profiles
  • 6.2.1. Boston Scientific Corporation
    • 6.2.1.1. Company overview
    • 6.2.1.2. Financial performance
    • 6.2.1.3. Product benchmarking
    • 6.2.1.4. Strategic initiatives
  • 6.2.2. Medtronic
    • 6.2.2.1. Company overview
    • 6.2.2.2. Financial performance
    • 6.2.2.3. Product benchmarking
    • 6.2.2.4. Strategic initiatives
  • 6.2.3. Cook
    • 6.2.3.1. Company overview
    • 6.2.3.2. Financial performance
    • 6.2.3.3. Product benchmarking
    • 6.2.3.4. Strategic initiatives
  • 6.2.4. B. Braun
    • 6.2.4.1. Company overview
    • 6.2.4.2. Financial performance
    • 6.2.4.3. Product benchmarking
    • 6.2.4.4. Strategic initiatives
  • 6.2.5. Terumo Medical Corporation
    • 6.2.5.1. Company overview
    • 6.2.5.2. Financial performance
    • 6.2.5.3. Product benchmarking
    • 6.2.5.4. Strategic initiatives
  • 6.2.6. Abbott
    • 6.2.6.1. Company overview
    • 6.2.6.2. Financial performance
    • 6.2.6.3. Product benchmarking
    • 6.2.6.4. Strategic initiatives
  • 6.2.7. Stryker
    • 6.2.7.1. Company overview
    • 6.2.7.2. Financial performance
    • 6.2.7.3. Product benchmarking
    • 6.2.7.4. Strategic initiatives
  • 6.2.8. Teleflex Incorporated
    • 6.2.8.1. Company overview
    • 6.2.8.2. Financial performance
    • 6.2.8.3. Product benchmarking
    • 6.2.8.4. Strategic initiatives
  • 6.2.9. BD
    • 6.2.9.1. Company overview
    • 6.2.9.2. Financial performance
    • 6.2.9.3. Product benchmarking
    • 6.2.9.4. Strategic initiatives

관련자료